WHO Approves Sinovac For Emergency Use
"); jQuery("#212 h3").html("
"); });
2021-06-01 HKT 22:54
Share this story
The World Health Organisation (WHO) has approved a Covid-19 vaccine made by Sinovac Biotech for emergency use listing, the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product's safety and efficacy. It would also allow the shot to be included in Covax, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems due to India's suspension of vaccine exports.
In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose two to four weeks later. There was no upper age limit as data suggested it is likely to have a protective effect in older people. (Reuters)
Tycoon Sits China's University Exams For 27th Time
Among the millions of fresh-faced high schoolers sitting the nation's dreaded "gaokao" college entrance exam on Wednesda... Read more
China's First Home-grown Large Cruise Liner Undocks
The first large cruise liner developed by China completed its undocking in Shanghai on Tuesday, marking its complete tra... Read more
Chinese, US Diplomats Hold 'frank' Talks In Beijing
Meetings between senior mainland and US officials in China this week struck an upbeat chord, with both sides agreeing to... Read more
China's Cruise Industry Set To Make Waves Again
China's cruise industry, suspended for more than three years due to the pandemic, is expected to resume operations in th... Read more
Toll From Deadly Landslide Rises To 19
All 19 people caught in a landslide in Sichuan province on Sunday have been confirmed dead, state media reported, announ... Read more
'Nato-like Alliance Disastrous For Asia-Pacific'
Defence Minister Li Shangfu on Sunday told the Shangri-La Dialogue security summit in Singapore that any moves to establ... Read more